In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now.
Incyte Corporation (NASDAQ:INCY) is one of the most undervalued biotech stocks to buy right now. RBC Capital raised the price ...
Telix Pharmaceuticals Ltd (ASX:TLX) has delivered a sharp reminder of how quickly sentiment can swing in biotech — with a ...
Seaport Therapeutics, a Boston biotech led by Daphne Zohar, has filed to go public, setting up a Nasdaq debut that could funnel fresh cash into its neuropsychiatric drug pipeline. Spun out of PureTech ...
Specialized laboratory relocation firm shares safety protocols and planning tips for moving precision instruments in ...
Initial results from a high-stakes trial indicate the biotech may have finally found a niche in lymphoma care for a ...
Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next ...
Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.
GlobalData on MSN
The innovators working to make in vivo cell therapy a reality
As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.
During the pharma earnings season, which begins on Tuesday, Novo Nordisk will report the first revenue numbers from an oral ...
Explore the evolving healthcare theme in the Rekha Rakesh Jhunjhunwala portfolio as of March 2026. This deep dive analyzes ...
Mesoblast offers asymmetric risk-reward with Ryoncil's rapid pediatric SR-aGvHD launch and multiple late-stage pipeline catalysts. Learn why MESO stock is a hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results